Official launch of the new vertebral fracture reduction (VFR) system, TEKTONA®2

Spineart is proud to announce the launch of its upgraded, and now single-use, TEKTONA®2 Vertebral Fracture Reduction System, featuring enhanced ergonomics and usability.

Aligned with the company’s goal of transforming spine surgery for patients, surgeons, and hospitals; Spineart has developed a minimally invasive technology that enables a targeted, controlled, and multidirectional reduction of the vertebral compression fracture with a fully repositionable instrument.

Combined with TEKTONA® HV Cement, TEKTONA®2 preserves the trabecular structure, while enabling a precise and efficient treatment of the fracture.

 To learn more about this differentiated technology, please visit (link to product page).

TEKTONA®2 is not FDA Approved.

More information here

Related

Related items
Date - Category Illustration Title Excerpt
  • Corporate
26 September 2025 Plan-Les-Ouates & Zurich (CH) – Antwerp (BE) Spineart (www.spineart.com), a global medtech innovator in advanced spine surgery solutions, today announces a CHF 25 million capital increase backed...
  • Product
Spineart announces the full-market launch of its SCARLET® AC-Ti secured anterior cervical cage in the United States. Following 510(k) clearance in May 2024, SCARLET® AC-Ti has been extensively evaluated by...
  • BAGUERA® C
Spineart today announces that it has completed a planned interim analysis for its 2-level BAGUERA® C IDE study, which showed that BAGUERA® C, its innovative cervical disc prosthesis, met the...